Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-22-022757

Options or other derivatives

  • CHIEF FINANCIAL OFFICER acquired 89,189 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FARR KEVIN M · CHIEF FINANCIAL OFFICER

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-08-12 Grant or award : show line 1 in the form Restricted Stock Unit +89,189 89,189 D
Loading xslF345X03/wf-form4_166035294656633.xml…